Next Article in Journal
Novel Targeted Agents in Advanced and Recurrent Low-Grade Serous Ovarian Cancer: A Silver Lining in the Therapy of a Chemoresistant Disease?
Next Article in Special Issue
Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study
Previous Article in Journal
The Multimodality Management of Malignant Peripheral Nerve Sheath Tumours
Previous Article in Special Issue
Long-Term Oral Tamoxifen Administration Decreases Brain-Derived Neurotrophic Factor in the Hippocampus of Female Long-Evans Rats
 
 
Review

Article Versions Notes

Cancers 2024, 16(19), 3267; https://doi.org/10.3390/cancers16193267
Action Date Notes Link
article xml file uploaded 26 September 2024 08:28 CEST Original file -
article xml uploaded. 26 September 2024 08:28 CEST Update https://www.mdpi.com/2072-6694/16/19/3267/xml
article pdf uploaded. 26 September 2024 08:28 CEST Version of Record https://www.mdpi.com/2072-6694/16/19/3267/pdf
article html file updated 26 September 2024 08:30 CEST Original file https://www.mdpi.com/2072-6694/16/19/3267/html
Back to TopTop